ERK2 drives tumour cell migration in three-dimensional microenvironments by suppressing expression of Rab17 and

Anne von Thun1, Marc Birtwistle, Gabriela Kalna

  • 1Beatson Institute for Cancer Research, Glasgow, G61 1BD, UK.

Journal of Cell Science
|February 14, 2012
PubMed

Insights

Extracellular signal-regulated kinase 2 (ERK2) is crucial for cancer cell invasion, not redundant with ERK1. Suppressing ERK2 impairs cell motility by regulating Rab17 and liprin-β2 gene expression.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • The extracellular signal-regulated kinase (ERK) pathway is implicated in tumor invasion and progression.
  • ERK1 and ERK2 isoforms were considered redundant due to high homology and similar in vitro kinase activity.

Purpose of the Study:

  • To investigate the specific roles of ERK1 and ERK2 in cancer cell invasion.
  • To challenge the notion of functional redundancy between ERK1 and ERK2.

Main Methods:

  • Silencing of ERK2 in MDA-MB-231 cells.
  • Re-expression of ERK1 or ERK2 following knockdown.
  • Quantitative analysis of cell migration on 3D matrices.
  • Gene expression profiling using arrays.

Main Results:

  • ERK2 silencing inhibited invasive migration of MDA-MB-231 cells, while ERK1 did not.
  • ERK2 knockdown decreased cell migration velocity and increased non-motile time.
  • Expression of Rab17 and liprin-β2 genes, which inhibit invasion, was upregulated by ERK2 knockdown.
  • Re-expression of ERK2, but not ERK1, restored normal invasiveness and gene expression levels.
  • Knockdown of Rab17 or liprin-β2 rescued invasiveness in ERK2-depleted cells.

Conclusions:

  • ERK2 plays a non-redundant, critical role in driving cancer cell invasion.
  • ERK2 promotes invasion by suppressing the expression of inhibitory genes Rab17 and liprin-β2.
  • These findings highlight ERK2 as a potential therapeutic target for inhibiting cancer metastasis.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However, invadopodia can...
Cell Polarization by Rho Proteins01:21

Cell Polarization by Rho Proteins

Cell polarity is the asymmetric distribution of cellular and membrane components, making one side of the cell different from the other. This polarity is essential to many processes such as embryogenesis, axon migration, glucose transport across epithelial cells, and directional cell migration. A migrating cell responds to intracellular or extracellular signals via molecular cascades that reorganize the actin cytoskeleton to establish this polarity. In these cells, the Rho family proteins Cdc42,...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...